Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001437749-26-002528·Monopar Therapeutics
Schedule 13D ownership disclosure
Monopar Therapeutics Inc
Common Stock, $0.001 par value · CUSIP: 61023L207
Event date: 2026-01-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Tactic Pharma LLCReported CIK 0001727357
Shares: 0.00 · Class: 0.0%
- Robinson ChandlerReported CIK 0001727334
Shares: 307,370.00 · Class: 4.5%
- Brown Michael JReported CIK 0001035909
Shares: 124,629.00 · Class: 1.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-26-002528
- Form type
- SCHEDULE 13D/A
- Filer
- Monopar Therapeutics
- CIK
- CIK 1645469
- Filed
- Jan 30, 2026
- Reporting period
- Jan 28, 2026
- Description
- Schedule 13D beneficial ownership